ArunA Biomedical to Present and Participate on a Panel at 2018 BIO International Convention

Details of the company presentation are as follows:
Title: Neural Exosomes: The Next Generation of CNS Therapeutics
Date: Monday, June 4, 2018
Time: 4:45-5:00pm ET
Location: Theater 4

Details of the panel presentation are as follows:
Title: Harnessing the Body’s Regenerative Capabilities – Therapeutic Development from the Clinic to Commercialization
Date: Tuesday, June 5, 2018
Time: 11:00-12:00pm ET
Location: Room 210B, Level 2, Boston Convention and Exhibition Center

To schedule a meeting with ArunA’s management team at the Convention, send them a meeting request through the BIO One-on-One Partnering™ system or contact the team at tstice@arunabio.com.

Exosomes as Therapeutics
Since their discovery more than 30 years ago, extracellular vesicles — nanometer-sized cell-signaling particles — have been increasingly found to play a role in intercellular communication, capable of delivering functional proteins, mRNA transcripts and miRNA to cells throughout the body. Exosomes have the potential to target any cell in the body and as proved in ArunA’s studies are capable of multiple administrations via IV and of crossing the blood brain barrier non-invasively to reach the site of injury. Exosomes have shown great promise as potential therapeutics and as vehicles to carry drug payloads to the site of injury or disease.

About ArunA Biomedical
At ArunA Biomedical, we are the experts in the design and scaling of neural-derived exosomes, developing a new class of cell-free biologics and cell-mediated drug delivery systems to treat CNS and neurodegenerative disorders. www.arunabio.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180524005312/en/